ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 214 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $523,629 | -20.6% | 39,850 | -21.1% | 0.06% | -48.8% |
| Q1 2023 | $659,221 | -27.2% | 50,515 | -1.6% | 0.12% | -43.3% |
| Q4 2022 | $905,179 | -39.1% | 51,314 | -48.8% | 0.22% | -45.8% |
| Q2 2022 | $1,487,000 | +105.7% | 100,246 | +212.3% | 0.40% | +105.1% |
| Q1 2022 | $723,000 | +0.6% | 32,095 | -40.4% | 0.20% | -16.7% |
| Q3 2021 | $719,000 | +6.7% | 53,807 | +19.8% | 0.23% | -43.5% |
| Q1 2021 | $674,000 | +114.6% | 44,907 | +40.5% | 0.41% | +331.2% |
| Q4 2019 | $314,000 | -38.6% | 31,970 | -27.2% | 0.10% | -58.6% |
| Q2 2019 | $511,000 | +176.2% | 43,898 | +126.3% | 0.23% | +154.9% |
| Q1 2019 | $185,000 | -76.5% | 19,394 | -70.4% | 0.09% | -85.0% |
| Q2 2018 | $787,000 | +32.0% | 65,624 | +36.1% | 0.60% | +20.8% |
| Q1 2018 | $596,000 | +146.3% | 48,224 | +183.8% | 0.50% | +155.6% |
| Q3 2017 | $242,000 | +34.4% | 16,992 | +20.4% | 0.20% | +17.4% |
| Q2 2017 | $180,000 | – | 14,110 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 10,507,149 | $138,799,000 | 8.42% |
| Tamarack Advisers, LP | 1,650,000 | $21,797,000 | 7.63% |
| Blue Harbour Group | 10,759,695 | $142,136,000 | 4.78% |
| BROADVIEW ADVISORS LLC | 1,095,800 | $14,476,000 | 2.08% |
| Rovida Advisors Inc. | 752,400 | $9,939,000 | 2.04% |
| Adirondack Research & Management Inc. | 361,259 | $4,772,000 | 1.73% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,104,400 | $14,589,000 | 1.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 14,401,161 | $190,239,000 | 1.62% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5,077,304 | $67,071,000 | 1.30% |
| Iguana Healthcare Management, LLC | 250,000 | $3,303,000 | 1.21% |